Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
1.130
+0.010 (0.89%)
At close: Sep 1, 2026, 4:00 PM EDT
1.142
+0.012 (1.09%)
After-hours: Sep 1, 2026, 7:21 PM EDT
Sunshine Biopharma Market Cap
Sunshine Biopharma has a market cap or net worth of $4.38 million as of September 1, 2026. Its market cap has decreased by -33.22% in one year.
Market Cap
4.38M
Enterprise Value
-8.97M
1-Year Change
-33.22%
Ranking
Category
Stock Price
$1.13
ChartMarket Cap Chart
Since October 30, 2009, Sunshine Biopharma's market cap has decreased from $1.68B to $4.38M, a decrease of -99.74%. That is a compound annual growth rate of -29.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 4.38M | -27.39% |
| Dec 31, 2025 | 6.03M | 0.59% |
| Dec 31, 2024 | 6.00M | -13.89% |
| Dec 29, 2023 | 6.97M | -51.79% |
| Dec 30, 2022 | 14.45M | -51.71% |
| Dec 31, 2021 | 29.93M | 474.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonoma Pharmaceuticals | 6.18M |
| Gelteq | 5.98M |
| InMed Pharmaceuticals | 5.89M |
| cbdMD | 5.60M |
| Apimeds Pharmaceuticals US | 5.34M |
| RedHill Biopharma | 5.29M |
| BioXcel Therapeutics | 4.29M |
| Akanda | 2.91M |